Suppr超能文献

供体吲哚菁绿清除试验可预测肝移植后的移植物质量和早期移植物预后。

Donor Indocyanine Green Clearance Test Predicts Graft Quality and Early Graft Prognosis After Liver Transplantation.

作者信息

Tang Yunhua, Han Ming, Chen Maogen, Wang Xiaoping, Ji Fei, Zhao Qiang, Zhang Zhiheng, Ju Weiqiang, Wang Dongping, Guo Zhiyong, He Xiaoshun

机构信息

Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan Er Road, Guangzhou, 510080, China.

Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China.

出版信息

Dig Dis Sci. 2017 Nov;62(11):3212-3220. doi: 10.1007/s10620-017-4765-x. Epub 2017 Sep 20.

Abstract

BACKGROUND

Transplantation centers have given much attention to donor availability. However, no reliable quantitative methods have been employed to accurately assess graft quality before transplantation. Here, we report that the indocyanine green (ICG) clearance test is a valuable index for liver grafts.

METHODS

We performed the ICG clearance test on 90 brain-dead donors within 6 h before organ procurement between March 2015 and November 2016. We also analyzed the relationship between graft liver function and early graft survival after liver transplantation (LT).

RESULTS

Our results suggest that the ICG retention rate at 15 min (ICGR15) of donors before procurement was independently associated with 3-month graft survival after LT. The best donor ICGR15 cutoff value was 11.0%/min, and we observed a significant increase in 3-month graft failure among patients with a donor ICGR15 above this value. On the other hand, a donor ICGR15 value of ≤ 11.0%/min could be used as an early assessment index of graft quality because it provides additional information to the transplant surgeon or organ procurement organization members who must maintain or improve organ function to adapt the LT.

CONCLUSION

An ICG clearance test before liver procurement might be an effective quantitative method to predict graft availability and improve early graft prognosis after LT.

摘要

背景

移植中心一直非常关注供体的可获得性。然而,在移植前尚未采用可靠的定量方法来准确评估移植物质量。在此,我们报告吲哚菁绿(ICG)清除试验是肝脏移植物的一个有价值的指标。

方法

我们在2015年3月至2016年11月期间,在器官获取前6小时内对90例脑死亡供体进行了ICG清除试验。我们还分析了肝移植(LT)后移植物肝功能与早期移植物存活之间的关系。

结果

我们的结果表明,获取前供体的15分钟吲哚菁绿滞留率(ICGR15)与LT后3个月的移植物存活独立相关。最佳的供体ICGR15临界值为11.0%/分钟,我们观察到供体ICGR15高于此值的患者3个月移植物失败率显著增加。另一方面,供体ICGR15值≤11.0%/分钟可作为移植物质量的早期评估指标,因为它为必须维持或改善器官功能以适应LT的移植外科医生或器官获取组织成员提供了额外信息。

结论

肝脏获取前的ICG清除试验可能是一种有效的定量方法,可预测移植物的可获得性并改善LT后的早期移植物预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验